HOME >> MEDICINE >> NEWS
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

ROCHESTER, Minn. -- A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at The International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.

Heart transplant patients are required to take daily immunosuppressive medication to prevent their body from rejecting the transplanted organ. Standard practice has been to treat patients primarily with calcineurin inhibitors. However, calcineurin inhibitors are a major cause of kidney dysfunction and do not prevent transplant coronary artery disease, a rapidly progressing coronary disease that develops in many heart transplant recipients and greatly limits long-term survival.

"Immunosuppression for heart transplant patients using calcineurin inhibitors has been essentially unchanged for 25 years, and the results have not been ideal," says Sudhir Kushwaha, M.D., the lead author and a cardiologist at Mayo Clinic. "Five to 10 years post-transplant, 10 percent of patients are on dialysis or need a kidney transplant. And 10 years post-transplant, 50 percent of patients are either waiting for another heart transplant because of coronary artery disease or have died as a result of it."

Dr. Kushwaha and a team of Mayo Clinic researchers collaborated to study alternative options for immunosuppression, using sirolimus, an anti-proliferative immunosuppression drug with potent anti-rejection properties.

One study involving 78 heart transplant patients over four years found that gradually transitioning stable patients from calcineurin inhibitors to sirolimus showed consistent improvement of kidney function. There was no increase in rejection of the transplanted heart and no difference in heart function.

A second study found gradual transition to sirolimus
'"/>

Contact: Elizabeth Rice
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
26-Apr-2007


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Clinical trial coordinators need more financial conflict-of-interest training

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... MARLBORO, N.J. (PRWEB) , ... August 31, 2020 ... ... the leading cloud-based business management solution for chiropractors, announced today the launch of ... telehealth, healthcare professionals can start running their virtual practice in under 90 seconds. ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis ... are in a state of panic, experiencing deep anxiety, immense stress, and right now are ... is timely when most people on the planet are experiencing a great degree of emotional ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy ... ease than most people would. Rather than become melancholic, however, he put together a ... achieving one’s dreams. Randy Pausch took a negative situation and turned it into something ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... Nourished Group set out to continue helping the specialty-diet community connect with ... new gluten-free products, get coupons, enter giveaways, chat with brands & watch over ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... ... has joined the Walk-in Dermatology team in its Greenvale, New York location. ... Nail and Skin Care Institute. She is certified in chemical peels, microdermabrasion, Hydrafacial ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... FALLS CHURCH, Va. (PRWEB) , ... September 03, 2020 , ... ... a Statistician, An FDAnews Webinar, Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, ... were also an expert statistician? , While one can’t become one in 90 ...
(Date:9/2/2020)... ... 2020 , ... U.S. Dermatology Partners is excited to welcome Board-Certified ... at Bethesda Dermatopathology Lab. , Jonathan Lee, MD grew up in the ... He went on to receive his M.D. with Honors from Harvard Medical School and ...
(Date:9/1/2020)... ... ... While coronavirus cases continue to increase across the country, blood drives are being ... about 80% of blood donations are made at drives hosted by these groups, the ... to ensure blood products are readily available for patients. , Those interested can ...
Breaking Medicine Technology:
Cached News: